share_log

RGC: CEO Figuratively Putting His Money Where His Mouth Is

Benzinga Real-time News ·  Jun 25, 2022 05:44

By Beth Senko, CFA

NASDAQ:RGC

Investors have faced challenging and volatile markets so far in 2022 as they sort through issues of inflation, supply chain disruption, continued covid issues, rising interest rates, and the disruption of the war in Ukraine. The S&P 500 has come close to bear market levels, down 19% in mid-June.

Times of turbulence affect all stocks, large and small. It can be particularly challenging for pre-revenue microcap stocks, where the volatility is often magnified by small changes in perception, whether driven by news or technical trading signals.

We first wrote on Regencell Bioscience (NASDAQ:RGC...

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment